Nobel Prize Recipient, Louis Ignarro, on Scientific Committee of “Fondazione Internazionale Menarini”

FLORENCE, Italy, Oct. 24, 2019 /PRNewswire/ — His discoveries have changed the lives of millions of people. Thanks to his insight, he has won the world’s most prestigious scientific honour. Today, his valuable experience will contribute towards bolstering the mission of the “Fondazione Internazionale Menarini” which welcomes the winner of the Nobel prize for Medicine, Louis Ignarro.

Born in Brooklyn (New York), the son of Italian immigrants, Ignarro discovered his love for chemistry at the age of 8 when he carried out his first experiments with a children’s game. This passion never faded and, after a brilliant academic career at the Columbia University in New York and long periods of research in other prestigious American universities, he joined the University of California, Los Angeles (UCLA). It was during this time that he was awarded the Nobel Prize for Medicine and Physiology “for his contribution in discovering the workings of the nitric acid molecule in the cardiovascular system.” It is to his studies that we owe the development of medicines commonly used in treating erectile dysfunction and hypertension. Ignarro is one of the founders of the Nitric Oxide Society and is currently Professor of Pharmacology in the Department of Molecular Medical Pharmacology at the UCLA School of Medicine.

Speaking from Los Angeles, Louis Ignarro, had this to say about this exciting collaboration with the Foundation: “Having taught in several American universities, I have always appreciated the work carried out by the Fondazione Internazionale Menarini: their educational activities at congresses and on the internet represent a unique scientific asset. Thanks to this collaboration, I shall continue to contribute to the scientific instruction of researchers, clinicians, students, and young people.”

“We are honoured to have Professor Ignarro join our Scientific Committee,” commented Lorenzo Melani, Chairman and Scientific Director of the Fondazione Internazionale Menarini. “With the help of his experience, we shall continue to further promote research and understanding in the fields of biology, pharmacology, medicine, economics, and human sciences, which represent the institutional aims of the Fondazione Internazionale Menarini.”

For further information on “Fondazione Internazionale Menarini” visit the website https://www.en.fondazione-menarini.it/.

Photo – https://healthtechnologynet.com/wp-content/uploads/2019/10/Louis_Ignarro.jpg
Logo – https://healthtechnologynet.com/wp-content/uploads/2019/10/Menarini_Logo.jpg

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/nobel-prize-recipient-louis-ignarro-on-scientific-committee-of-fondazione-internazionale-menarini-300945011.html

SOURCE Menarini I.F.R.

Staff

Recent Posts

Medexus Schedules Third Fiscal Quarter 2026 Conference Call

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - February 3, 2026) - Medexus Pharmaceuticals (TSX: MDP)…

21 minutes ago

In HelloNation, Family Counseling Expert Scott Ostrowski of Geneva Outlines Employee and Employer Support Services for HelloNation

GENEVA, N.Y., Feb. 3, 2026 /PRNewswire/ -- What are Employee and Employer Support Services, and…

21 minutes ago

In HelloNation, Dental Lab Specialist Jeffrey Tolksdorf of Clinton Township, MI, Details What Happens Inside a Dental Lab

CLINTON TOWNSHIP, Mich., Feb. 3, 2026 /PRNewswire/ -- What actually happens after your dentist takes…

21 minutes ago

In HelloNation, Water Treatment Expert Jason McGee of Loretto Explains the Importance of Precision in Water Treatment Chemistry

LORETTO, Tenn., Feb. 3, 2026 /PRNewswire/ -- How does precision in chemical dosing affect the…

21 minutes ago

GLOBO Language Solutions Elevates Leadership with Executive Promotions

PHILADELPHIA, Feb. 3, 2026 /PRNewswire/ -- GLOBO Language Solutions, the leading B2B provider of interpreting and…

21 minutes ago

Specialty1 Partners Continues to Accelerate Growth Through Its Industry-Leading Joint Venture Model

HOUSTON, Feb. 3, 2026 /PRNewswire/ -- Specialty1 Partners (S1P), the nation's fastest growing specialty dental…

21 minutes ago